Clinical Trial Update: Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tiotropium 18 mcg in chronic obstructive pulmonary disease patients with a concurrent respiratory infection; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2014-04-10